Clinical significance of Fibro Touch,ultrasound,and computed tomography in diagnosis of fatty liver disease: a comparative analysis

Li JingBo; Liu Shu; Wen Bo; Gao Nan; Wang BingYuan

doi:10.3969/j.issn.1001-5256.2016.03.011

Issue 3

Mar. 2016

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2016 > 32(3): 459-462

PDF( 1978 KB)

Clinical significance of Fibro Touch,ultrasound,and computed tomography in diagnosis of fatty liver disease: a comparative analysis

DOI: 10.3969/j.issn.1001-5256.2016.03.011

Department of Geriatric Medicine,The First Affiliated Hospital of China Medical University

Received Date: 2015-08-08
Published Date: 2016-03-20

Abstract

Abstract

Objective To investigate the clinical significance of image- guided transient elastography Fibro Touch with fat attenuation parameter( FAP) in the diagnosis of fatty liver disease. Methods A total of 1080 persons who underwent physical examination in The First Affiliated Hospital of China Medical University from January to December,2014 were enrolled,and liver FAP,the results of color Doppler ultrasound for the liver,and liver / spleen CT ratio on computed tomography( CT) scan for the liver were collected and analyzed. The Kruskal- Wallis H test was applied for comparison of continuous data between groups,and the Kappa consistency coefficient and receiver operating characteristic curve were used to investigate the consistency between FAP and the results of color Doppler ultrasound for the liver or liver / spleen CT ratio on CT scan for the liver in the diagnosis of fatty liver disease and their diagnostic values. Results Liver ultrasound found 336 patients( 31. 11%) without fatty liver disease and 744 patients( 68. 89%) with fatty liver disease; with reference to the results of ultrasound,the sensitivity and specificity of Fibro Touch were 80. 5% and 75. 3%,respectively. Liver CT found 821 patients( 76. 02%)without fatty liver disease( grade 0) and 259 patients with fatty liver disease,among whom 216 had mild fatty liver disease( grade 1),34 had moderate fatty liver disease( grade 2),and 9 had severe fatty liver disease( grade 3); with reference to the results of liver CT,the sensitivity and specificity of Fibro Touch were 95. 4% and 47. 0%,respectively,and the sensitivity and specificity of ultrasound were 93. 1%and 36. 8%,respectively. As for the diagnosis of fatty liver disease,the results of Fibro Touch had a higher consistency with ultrasound results( Kappa coefficient = 0. 597,P < 0. 0001),and a lower consistency with CT results( Kappa coefficient = 0. 113,P < 0. 0001). Conclusion Fibro Touch has the advantages of high accuracy,easy operation,noninvasiveness,and low cost,and therefore it is a promising imaging method for the diagnosis of fatty liver disease.
- fatty liver,
- elasticity imaging technigues,
- ultrasonic B,
- computed tomography

FullText(HTML)

References(26)

References

[1]FAN JG.Epidemiology of alcoholic and nonalcoholic fatty liver disease in China[J].J Gastroenterol Hepatol,2013,28(Suppl 1):11-17.

[2]FESTI D,SCHIUMERINI R,MARZI L,et al.Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods[J].Aliment Pharmacol Ther,2013,37(4):392-400.

[3]ANSTEE QM,TARGHER G,DAY CP.Progression of NAFLD to diabetes mellitus,cardiovascular disease or cirrhosis[J].Nat Rev Gastroenterol Hepatol,2013,10(6):330-344.

[4]European Association for the study of the Liver.EASL clinical practical guidelines:management of alcoholic liver disease[J].J Hepatol,2012,57(2):399-420.

[5]Expert Committee on the Diagnosis and Management of Fatty Liver Disease,Chinese Medical Association.Recommendation for the standardization of diagnosis and treatment of fatty liver disease[J].J Clin Hepatol,2013,29(9):652-655.(in Chinese)中国医师协会脂肪性肝病专家委员会.脂肪性肝病诊疗规范化的专家建议[J].临床肝胆病杂志,2013,29(9):652-655.

[6]NASCIMBENI F,PAIS R,BELLENTANI S,et al.From NAFLD in clinical practice to answers from guidelines[J].J Hepatol,2013,59(4):859-871.

[7]CASTERRA L,VILGRAIN V,ANGULO P.Noinvasive evaluation of NAFLD[J].Nat Rev Gastroenterol Hepatol,2013,10(11):666-675.

[8]KHOV N,SHARMA A,RILEY TR.Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease[J].World J Gastroenterol,2014,20(22):6821-6825.

[9]MYERS RP,POLLETT A,KIRSCH R,et al.Controlled attenuation parameter(CAP):a noninvasive method for the detection of hepatic steatosis based on transient elastography[J].Liver Int,2012,32(6):902-910.

[10]CHAN WK,NIK MUSTAPHA NR,MAHADEVA S.Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease[J].J Gastroenterol Hepatol,2014,29(7):1470-1476.

[11]CHON YE,JUNG KS,KIM SU,et al.Controlled attenuation parameter(CAP)for detection of hepatic steatosis in patients with chronic liver diseases:a prospective study of a native Korean population[J].Liver Int,2014,34(1):102-109.

[12] SASSO M,TENGHER-BARNA I,ZIOL M,et al.Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan:validation in chronic hepatitis C[J].J Viral Hepat,2012,19(4):244-253.

[13]SCAGLIONI F,CICCIA S,MARION M,et al.ASH and NASH[J].Dig Dis,2011,29(2):202-210.

[14] VERNON G,BARANOVA A,YOUNOSIS ZM.Systematic review:the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults[J].Aliment Pharmacol Ther,2011,34(3):274-285.

[15]WANG FS,FAN JG,ZHANG Z,et al.The global burden of liver disease:the major impact of China[J].Hepatology,2014,60(6):2099-2108.

[16]HU X,HUANG Y,BAO Z,et al.Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units[J].BMC Gastroenterol,2012,12(35):123.

[17]CARVALHANA S,LEITO J,ALVES AC,et al.How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population:correlation with ultrasound[J].Liver Int,2014,34(6):e111-e117.

[18]FERRAIOLI G,TINELLI C,LISSANDRIN R,et al.Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis[J].World J Gastroenterol,2014,20(21):6626-6631.

[19]KUMAR M,RASTOGI A,SINGH T,et al.Controlled attenuation parameter for non-invasive assessment of hepatic steatosis:does etiology affect performance?[J].J Gastroenterol Hepatol,2013,28(7):1194-1201.

[20]SCHWEZER NF,SPRINGER F,SCHRAML C,et al.Noninvasive assessment and quantification of liver steatosis by ultrasound,computed tomography and magnetic resonance[J].J Hepatol,2009,51(3):433-445.

[21]MEHTA SR,THOMAS EL,BELL JD,et al.Noninvasive means of measuring hepatic fat content[J].World J Gastroenterol,2008,13(22):3476-3483.

[22]ZEB I,LI D,NASIR KG,et al.Computed tomography scans in the evaluation of fatty liver disease in a population based study:the multi-ethnic study of atherosclerosis[J].Acad Radiol,2012,19(7):811-818.

[23] MYERS RP,POLLETT A,KIRSCH R,et al.Controlled attenuation parameter(CAP):a noninvasive method for the detection of hepatic steatosis based on transient elastography[J].Liver Int,2012,32(6):902-910.

[24]SHEN Y,ZHANG J,CAI H,et al.Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus:a cross-sectional study with pair-matched controls[J].BMC Gastroenterology,2015,15(1):32.

[25]PARK SK,SEO MH,SHIN HC,et al.Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men:5-year prospective cohort study[J].Hepatology,2013,57(4):1378-1383.

[26]de LEDINGHEN V,VERGNIOL J,FOUCHER J,et al.Non-invasive diagnosis of liver steatosis using controlled attenuation parameter(CAP)and transient elastography[J].Liver Int,2012,32(6):911-918.

Relative Articles

Supplements(0)

Cited By

Cited by

Periodical cited type(17)

1.	杨文帅，王立坤，董聪慧，武永萍，石栓柱. 瞬时弹性成像技术联合血清游离脂肪酸对非酒精性脂肪性肝病的诊断价值. 转化医学杂志. 2024(09): 1330-1335 .
2.	崔会鹏，田昊宇，关琳，李异玲. 代谢相关性脂肪性肝病无创诊断方法研究进展. 胃肠病学和肝病学杂志. 2022(01): 99-103 .
3.	凡军芳，胡静，耿旭，庄兰艮，时照明. 2型糖尿病患者肝脏受控衰减参数与血清25-羟维生素D的相关性. 中华全科医学. 2021(05): 794-797 .
4.	陈雅洁，李昭贤，王洋，曹经琳，窦剑. 瞬时弹性成像技术在肝移植围手术期应用的研究进展. 中华器官移植杂志. 2021(08): 501-504 .
5.	林俊红，林常青，翁娜，刘宴伟. 中年女性高血压体检者体质指数异常与脂肪肝发病率的相关性研究及护理干预. 全科护理. 2020(10): 1212-1214 .
6.	张晓静，林淑珍，张志安，温美兰. FibroTouch技术在诊断非酒精性脂肪性肝病患者肝脂肪变程度中的应用. 临床医学. 2020(04): 79-80 .
7.	李萍英，李娟，谢守珍，杨永耿，陆伦根. FibroTouch联合超声和CT检查诊断高原地区非酒精性脂肪性肝病临床应用研究. 实用肝脏病杂志. 2020(06): 817-820 .
8.	李正鑫，陈洋溢，赵志敏，吕靖，陈高峰，刘成海. 基于肝脏病理学对慢性乙型肝炎肝硬化患者FibroTouch测量值的影响因素分析. 临床肝胆病杂志. 2019(02): 338-344 . 本站查看
9.	陈中淑. 超声检查在诊断脂肪肝方面的临床应用价值. 当代医药论丛. 2019(10): 26-28 .
10.	何义华，罗建君，文安怡，程志生，余志映，吴舒婷. 二至解酲汤治疗酒精性肝病临床研究. 中医学报. 2018(06): 1099-1102 .
11.	何妙峰. 腹部B超对健康体检者脂肪肝筛查的价值分析. 深圳中西医结合杂志. 2018(10): 90-91 .
12.	王晴晴，胡明芬，杨红洁，禹蔚琴，柏保利，匡小林，庄林. B超在慢性HBV携带者合并非酒精性脂肪性肝病诊断中的应用. 肝脏. 2018(08): 723-727 .
13.	王新. 脂肪肝与病毒性肝炎B超鉴别诊断结果的对比研究. 心理月刊. 2018(04): 47-48 .
14.	张志伟. 肝功能与血清学指标水平检验对脂肪肝的诊断价值分析. 中外医疗. 2018(34): 11-13 .
15.	南胜天. CT及B超在脂肪肝临床诊断中应用的价值. 甘肃科技. 2017(07): 102-103 .
16.	庄小芳，孙洁，王晓波，王燕，吴琦琦，王晓忠. 瞬时弹性成像技术诊断非酒精性脂肪性肝病的性能评估. 临床肝胆病杂志. 2017(12): 2366-2371 . 本站查看
17.	杨杰，曹玉芝，徐永升，王雪，刘闯. 373例非酒精性脂肪性肝病FibroTouch检测临床观察. 中国实用医药. 2017(24): 33-34 .

Other cited types(12)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2798) PDF downloads(466)

Clinical significance of Fibro Touch,ultrasound,and computed tomography in diagnosis of fatty liver disease: a comparative analysis

DOI: 10.3969/j.issn.1001-5256.2016.03.011